<DOC>
	<DOCNO>NCT00959400</DOCNO>
	<brief_summary>Eligible patient agree participate migrate oral opioids transdermal patch follow four week . Oral morphine provide pain rescue medication . The patient inform adverse event rescue medication consumption . The number Fentanest® patch adjust every visit aim reduce rescue medication consumption adverse event minimum . The WHO-QOL- bref ( quality life questionary ) fill use Fentanest® . Patients show benefit eligible 3 week compassionate study .</brief_summary>
	<brief_title>Efficacy Safety Study Fentanyl Transdermal ( Fentanest® )</brief_title>
	<detailed_description />
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Male female outpatient age 18 70 year cancer chronic pain receive last 4 week least 40 mg oral morphine equianalgesic dose opioids . If use adjuvant analgesic , must stable dos last 4 week . Life expectancy bellow 4 month ; Karnofsky score &lt; 60 ; Hypersensitivity opioids patch ; Acute pain ; Non cancer pain ; Increased intracranial pressure ; Conditions prevent patient understand study direction and/or give consent ; Neuromuscular disorder increase risk respiratory depression ; Impossibility receive rescue oral morphine ; active infection ; Fever ; Pregnancy nursing ; Uncontrolled diabetes mellitus arterial hypertension ; Need anticoagulation ; Need operate machine vehicle ; Important skin disorder ; History severe allergic reaction ; BMI ≥ 35 ; Safety exams outrange ; Participation another clinical trial within last 2 month ; Investigator´s opinion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Fentanyl Transdermal</keyword>
	<keyword>Pain</keyword>
	<keyword>Cancer</keyword>
</DOC>